Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Adminis (Q63322740)
Jump to navigation
Jump to search
scientific article published on 01 November 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Adminis |
scientific article published on 01 November 2003 |
Statements
Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group (English)
Xavier Muracciole
Jean-Marc Tourani
Christian Pfister
Mahmoud Ouldkaci
Gilles Prevot
Virginie Lucas
Stéphane Oudard
Maxime Malet
Paul Cottu
Jean-Marc Ferrero
Didier Mayeur
Xu-Shan Sun
Olivier Bernard
Christophe Tournigand
Joelle Guilhot
Olivier Rixe
Subcutaneous Administration Propeukin Program Cooperative Group
1 November 2003